Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA
about
Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafAReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementControl of cell identity in pancreas development and regenerationMicroRNAs in insulin resistance and obesityTranscription factor regulation of pancreatic organogenesis, differentiation and maturationMicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2Dβ-Cell Replacement Strategies: The Increasing Need for a "β-Cell Dogma".Human β-cell regeneration: progress, hurdles, and controversy.De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar.A small-molecule inducer of PDX1 expression identified by high-throughput screening.Differential Gene Expression in GPR40-Overexpressing Pancreatic β-cells Treated with Linoleic Acid.Reprogramming Mouse Cells With a Pancreatic Duct Phenotype to Insulin-Producing β-Like CellsIdentification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells.In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ductsDirect Reprogramming for Pancreatic Beta-Cells Using Key Developmental GenesCiliated cells of pseudostratified airway epithelium do not become mucous cells after ovalbumin challenge.Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells.Mesenchymal Stem Cells Derived from Human Exocrine Pancreas Spontaneously Express Pancreas Progenitor-Cell Markers in a Cell-Passage-Dependent MannerStage specific reprogramming of mouse embryo liver cells to a beta cell-like phenotype.Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming.Preventing diabetes mellitus in developing countries.Beta cell dynamics: beta cell replenishment, beta cell compensation and diabetes.Targeting the pancreatic β-cell to treat diabetes.Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.New Insights into Diabetes Cell Therapy.Cellular reprogramming for clinical cartilage repair.V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting CellsReprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors.Late-stage differentiation of embryonic pancreatic β-cells requires Jarid2Reprogramming human gallbladder cells into insulin-producing β-like cells.Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist.Rejuvenating liver and pancreas through cell transdifferentiation.Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.Targeted Mutation of NGN3 Gene Disrupts Pancreatic Endocrine Cell Development in Pigs.Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts.
P2860
Q21559495-5EEE803F-06AB-4944-ADBD-DFDA053B4625Q26769878-6FB0B84B-0B32-47E8-8216-092B6D7C976DQ27021239-386815EE-4C5A-44D3-9DC6-C0DC53509039Q27023327-E666E349-1352-4677-8451-78D79BEFCEBAQ28083955-9F8CCD31-77DB-4155-8963-0335A75D0F94Q28547296-C6698E2E-C17F-47E4-8561-0BD2A96E19F9Q33766081-3BC24BD6-AD8C-46AD-B2C2-327CC448A06FQ33776142-3449934E-867B-466F-99B8-137EC55898EEQ34409239-2C889B6F-00D1-4251-A211-3299BC75BCA6Q34570650-EE43E024-F035-4736-9450-1FC96BE2F2BDQ35056869-3C818E9E-274C-4732-B193-04AB124231CBQ35127471-A62C898A-5BE2-4EC9-A976-DA66880F891EQ35603316-537715A5-B2F8-4772-BE0E-05E0129DD13AQ35874596-E68E9AE7-5313-4CA3-8D7E-805C67AB53E7Q36279958-18237D04-F3D8-4E5C-A273-C8F9548B91EFQ36701276-C13154A4-0A5F-4CD5-9EE9-16C5934BE27EQ36703966-F7AB9D2A-4DD7-44BE-9297-20F861B3A18CQ37030974-1C3B096D-FA2C-4E3E-AE37-9A334EBB11D7Q37223035-E354DD9B-A063-4F25-BDEE-385ECD6291CCQ37333141-0A6B199F-2DEA-4D7B-A5D2-C2D5EE6941A9Q37613069-535B6165-4663-4ABC-8DFB-32801C697DBDQ38001362-DE1371F9-57AF-45BC-AD60-7B088440C4EAQ38088672-0629740E-90D1-4B8E-B85A-8B8BA03670D9Q38187862-8E4DBFC7-4EE7-48E9-B5E0-366863D78821Q38651610-1C9E6494-DB0C-4856-A301-92FD12402DC0Q38777299-59634DEA-2757-4A9F-B93C-477E0E9BF9BAQ39112953-E920D5EA-1D66-47ED-96F2-5C206D2AD739Q39609204-4020B2F1-7630-4844-B804-D2844D3D52C9Q40750820-A544151C-B579-42C8-8B2F-63BA641232D5Q41051113-94DE2B2D-8CFA-4BEC-90EB-34FAB5572E13Q41432895-5ECEB724-28FE-49EF-9B4E-F1B7222823F2Q41850316-A7D5E78C-248B-4567-AAF4-1DB2BD7DE7F8Q41850952-DE9BEDFC-1F7C-4290-BF32-0B610D6F1686Q47557792-9B0AFDE1-E54B-4D9E-BA24-2BAB3E7F65B4Q50421781-38CD170E-946F-4A6C-927C-BA8D5CE1D65CQ50455092-5239F3E2-864A-4605-B53E-ABE01620C0D5Q52650846-F35DFBFD-410B-40A3-BDCE-3FFF0E2C9BF6
P2860
Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@ast
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@en
type
label
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@ast
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@en
prefLabel
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@ast
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@en
P2093
P2860
P356
P1433
P1476
Reprogramming of pancreatic ex ...... cter using Pdx1, Ngn3 and MafA
@en
P2093
Anannya Banga
Ersin Akinci
James R Dutton
Jonathan M W Slack
Lucas V Greder
P2860
P304
P356
10.1042/BJ20111678
P407
P577
2012-03-01T00:00:00Z